Search Tufts Medicine

Search Filters
Content type
medical-person
Need care for your condition?
Displaying 21 - 25 of 25
clinical trial
...

This research study is a 3-week clinical trial of dronabinol, a synthetic form of tetrahydrocannabinol (THC). This study is being done to determine if dronabinol is a safe and effective treatment for agitation symptoms related to Alzheimer’s disease. This study will compare dronabinol to a placebo.
clinical trial
...

The purpose of this study is to see if the study drug, elezanumab, is safe and able to improve cognitive and/or motor functioning in an individual following the occurrence of acute ischemic stroke. This is a 52-week, Phase 2a, randomized, double-blind, parallel-group, placebo-controlled, multicenter proof-of concept study.
clinical trial
...

The purpose of this study is to see if the study drug, elezanumab, is safe and able to improve function in patients with acute traumatic cervical spinal cord injury (SCI).
page
...
The faculty and team of the Institute for Clinical Research and Health Policy Studies (ICRHPS) at Tufts Medical Center regularly present their research in articles published in the world’s most prestigious, peer-reviewed journals and by the Agency for Healthcare Research and Quality.